Crossmark Global Holdings’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$752K Buy
2,397
+127
+6% +$39.9K 0.01% 716
2025
Q1
$692K Buy
2,270
+315
+16% +$96K 0.01% 731
2024
Q4
$649K Sell
1,955
-5,873
-75% -$1.95M 0.01% 728
2024
Q3
$2.61M Buy
7,828
+1,793
+30% +$599K 0.05% 350
2024
Q2
$2.49M Sell
6,035
-143
-2% -$58.9K 0.05% 355
2024
Q1
$2.5M Sell
6,178
-245
-4% -$99K 0.05% 370
2023
Q4
$1.97M Sell
6,423
-123
-2% -$37.7K 0.04% 402
2023
Q3
$1.61M Buy
6,546
+2,634
+67% +$649K 0.04% 443
2023
Q2
$997K Buy
3,912
+17
+0.4% +$4.33K 0.02% 589
2023
Q1
$733K Buy
3,895
+92
+2% +$17.3K 0.02% 671
2022
Q4
$807K Sell
3,803
-1,362
-26% -$289K 0.02% 621
2022
Q3
$812K Sell
5,165
-316
-6% -$49.7K 0.02% 605
2022
Q2
$820K Sell
5,481
-369
-6% -$55.2K 0.02% 631
2022
Q1
$957K Buy
5,850
+3,220
+122% +$527K 0.02% 639
2021
Q4
$572K Sell
2,630
-3,150
-54% -$685K 0.01% 835
2021
Q3
$1.09M Sell
5,780
-350
-6% -$66.2K 0.03% 582
2021
Q2
$1.08M Sell
6,130
-260
-4% -$45.9K 0.03% 582
2021
Q1
$1.05M Buy
6,390
+50
+0.8% +$8.2K 0.03% 575
2020
Q4
$883K Buy
6,340
+590
+10% +$82.2K 0.02% 605
2020
Q3
$643K Sell
5,750
-210
-4% -$23.5K 0.02% 677
2020
Q2
$554K Buy
5,960
+270
+5% +$25.1K 0.02% 714
2020
Q1
$418K Sell
5,690
-50
-0.9% -$3.67K 0.02% 709
2019
Q4
$483K Sell
5,740
-2,390
-29% -$201K 0.01% 822
2019
Q3
$683K Sell
8,130
-130
-2% -$10.9K 0.02% 657
2019
Q2
$540K Sell
8,260
-810
-9% -$53K 0.02% 777
2019
Q1
$535K Buy
+9,070
New +$535K 0.02% 779